Desipramine (2.5-5 mg/kg) increases the urinary excretion of amphetamine given intraperitoneally at doses of 75-15 mg/kg and it decreases the excretion ofp-hydroxyamphetamine. The rate of removal of brain amphetamine is decreased by desipramine (5 mg/kg, i.p.) when amphetamine is injected intraperitoneally but not when it is injected intracerebrally. It is suggested that desipramine impairs the hydroxylation of amphetamine in the liver thereby increasing the level of circulating amphetamine and eventually of brain amphetamine.MIPRAMINE and other tricyclic antidepressant agents are known to I increase and prolong the pharmacological effects of (+)-amphetamine showed that imipramine and desipramine prolong the hyperthermia induced by amphetamine in rats and that they also increase the amphetamine levels in brain and liver.These findings prompted an investigation to establish whether desipramine was able to affect the formation of p-hydroxyamphetamine, the major metabolite of amphetamine in rats (Axelrod, 1954a, b; Alleva, 1963; Dring, Smith & Williams, 1966).
Materials and methodsMale Sprague-Dawley rats, 165 5 g, were kept in Makrolon cages at constant room temperature (22") and relative humidity (60%). (+)-Amphetamine sulphate and desipramine were injected intraperitoneally and the urines were collected 24 hr after dosing.Amphetamine and p-hydroxyamphetamine were determined in urine and amphetamine in brain by the method of Axelrod (1954 a, b). Free p-hydroxyamphetamine was determined in urines before acid hydrolysis. Suitable controls indicated that desipramine did not interfere with the determination of urinary amphetamine or p-hydroxyamphetamine. The brains of animals pretreated with desipramine (5 mg/kg i.p.) did not affect the recovery of (+)-amphetamine added in vitro.In some experiments (+)-amphetamine was introduced into the brain by the method of Valzelli (1964). Table 1 gives the results obtained on measuring amphetamine and p-hydroxyamphetamine in urines of rats treated with different doses of amphetamine alone or with desipramine. It is evident that desipramine treatment changed the pattern of amphetamine metabolism by increasing the urinary excretion of amphetamine and decreasing that of p-hydroxyamphetamine.
Results